본문 바로가기

‘항암화학요법을 받은 폐암 환자의 예비 통합의학 임상경로’ 개발 및 타당도 평가

Development and Validity Test on Preliminary Critical Pathway of Integrative Medicine for Lung Cancer Patients Treated with Chemotherapy

문서 유형
연구출판물 · 학술지 논문
등재
KCI
저널
대한한방내과학회지38(6) · pp.917 · 2017
피인용
KCI 7
ISSN
1226-9174

저자

  1. 홍미나제1저자부산대학교
  2. 심소현부산대학교
  3. 윤성훈양산부산대학교병원
  4. 최준용부산대학교
  5. 김윤성교신저자부산대학교

초록

Objectives: The objective of this study was to investigate the validity of the preliminary critical pathway of integrative medicine to improve the quality of life of lung cancer patients who received chemotherapy. Methods: The vertical axis of the preliminary critical pathway of integrated medicine consisted of nine domains: assessment, treatment, activity, consult, diet, medication, Korean medical examination, education, and others. The frame of the horizontal axis was the date from hospitalization to discharge. A total of 105 items in this preliminary critical pathway were validated by an expert group from October 28, 2016 to November 4, 2016. A total of ten experts from two different medical institutions participated in the validity test, using the four-point Content Validity Index (CVI) scale. The items with validity of greater than 80% were considered as significant. Results: The analysis of the content validity of 105 items showed 102 items with greater than 80% agreement. Assessment, treatment, consult, diet, medication, and education showed 100% agreement. Only three items showed a low validity (62.5%). Based on additional comments, the preliminary critical pathway of integrative medicine has been supplemented. Conclusions: This study suggests the possibility of using the integrated medical critical pathway for patients with lung cancer who received chemotherapy.

키워드

lung cancercritical pathwaycontent validityintegrative medicine

식별자

KCI
ART002309689